Related references
Note: Only part of the references are listed.Design, Synthesis and Pharmacological Evaluation of Novel Piperlongumine derivatives as Potential Antiplatelet Aggregation Candidate
Yujun Wang et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2016)
Oncogene addiction: pathways of therapeutic response, resistance, and road maps toward a cure
Raymond Pagliarini et al.
EMBO REPORTS (2015)
The re-emergence of natural products for drug discovery in the genomics era
Alan L. Harvey et al.
NATURE REVIEWS DRUG DISCOVERY (2015)
Synthesis and biological evaluation of piperlongumine derivatives as potent anti-inflammatory agents
Young Hwa Seo et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2014)
Design, synthesis and biological activity of piperlongumine derivatives as selective anticancer agents
Yuelin Wu et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2014)
Mechanistic elucidation of apoptosis and cell cycle arrest induced by 5-hydroxymethylfurfural, the important role of ROS-mediated signaling pathways
Ling Zhao et al.
FOOD RESEARCH INTERNATIONAL (2014)
Natural product and natural product derived drugs in clinical trials
Mark S. Butler et al.
NATURAL PRODUCT REPORTS (2014)
Piperlongumine selectively kills cancer cells and increases cisplatin antitumor activity in head and neck cancer
Jong-Lyel Roh et al.
ONCOTARGET (2014)
Cancer wars: natural products strike back
Christine Basmadjian et al.
FRONTIERS IN CHEMISTRY (2014)
Piperlongumine induces pancreatic cancer cell death by enhancing reactive oxygen species and DNA damage
Harsharan Dhillon et al.
TOXICOLOGY REPORTS (2014)
Synthesis and biological evaluation of new piplartine analogues as potent aldose reductase inhibitors (ARIs)
Vidadala Ramasubba Rao et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2012)
Natural Products As Sources of New Drugs over the 30 Years from 1981 to 2010
David J. Newman et al.
JOURNAL OF NATURAL PRODUCTS (2012)
Synthesis, cellular evaluation, and mechanism of action of piperlongumine analogs
Drew J. Adams et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Natural products: An evolving role in future drug discovery
Bhuwan B. Mishra et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2011)
Natural products and Pharma 2011: Strategic changes spur new opportunities
Guy T. Carter
NATURAL PRODUCT REPORTS (2011)
被撤回的出版物: Selective killing of cancer cells by a small molecule targeting the stress response to ROS (Retracted article. See vol. 561, pg. 420, 2018)
Lakshmi Raj et al.
NATURE (2011)
Selective oxycution?
Darren J. Burgess
NATURE REVIEWS DRUG DISCOVERY (2011)
Photochemical Rearrangement of N-Chlorolactams: A Route to N-Heterocycles through Concerted Ring Contraction
Dana K. Winter et al.
JOURNAL OF ORGANIC CHEMISTRY (2010)
Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?
Dunyaporn Trachootham et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
Organometallic enantiomeric scaffolding:: General access to 2-substituted oxa- and azabicyclo[3.2.1]octenes via a bronsted acid catalyzed [5+2] cycloaddition reaction
Ethel C. Garnier et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2008)
Share Paper
